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Abstract: Otitis media (OM) has numerous presentations in children.
Together with conventional medical therapies aimed to prevent and/or
treat OM, a rising number of complementary and alternative medicine
(CAM) treatment options can be offered. Since OM is common in
children, parents may ask healthcare professionals about possible CAM
therapies. Many physicians feel that their knowledge is limited regard-
ing these therapies, and that they desire some information. Therefore,
we conducted a literature review of CAM therapies for OM, taking into
account that many of these treatments, their validity and efficacy and
have not been scientifically demonstrated.
We performed a search in MEDLINE (accessed via PubMed) using
the following terms: ‘‘CAM’’ in conjunction with ‘‘OM’’ and ‘‘chil-
dren. Retrieved publications regarding treatment of OM in children
which included these terms included randomized controlled trials,
prospective/retrospective studies, and case studies.
The following CAM options for OM treatment in children were
considered: acupuncture, homeopathy, herbal medicine/phytotherapy,
osteopathy, chiropractic, xylitol, ear candling, vitamin D supplement,
and systemic and topical probiotics. We reviewed each treatment and
described the level of scientific evidence of the relevant publications.
The therapeutic approaches commonly associated with CAM are
usually conservative, and do not include drugs or surgery. Currently,
CAM is not considered by physicians a potential treatment of OM, as
there is limited supporting evidence. Further studies are warranted inon Ovnat Tamir, M tta, MD,
usanna Esposito, MD
Abbreviations: AHS = a-hemolytic Streptococcus, AOM = acute
otitis media, CAM = complementary and alternative medicine, CI =
confidence interval, ET = Eustachian tube, 25(OH)D = 25-
hydroxyvitamin D, OM = otitis media, OMT = osteopathic
manipulative treatment, RAOM = recurrent AOM, RCT =
randomized controlled trial, SMT = spinal manipulation therapy,
URTI = upper respiratory tract infection.
INTRODUCTION
A lternative medicine is any practice claiming to possess thehealing effects of conventional medicine, but does not
originate from evidence-based scientific methods.1 It consists
of a range of healthcare practices, products, and therapies,
ranging from being biologically plausible but not scientifically
tested, to being directly contradicted by evidence, or even
harmful or toxic. Complementary medicine is an alternative
medicine used in conjunction with conventional medicine, in a
belief that it may be synergistic.2
Complementary and alternative medicine (CAM) is pop-
ular worldwide. Expenditure on CAM experts visits and thera-
pies in children is constantly growing.3 The main reasons for
choosing CAM therapies are that CAM attempts to provide a
personalized approach to the sick child, parents’ disappointment
with conventional medicine, personal or professional recom-
mendations, and parents’ previous experience. Despite signifi-
cant expenditures on testing CAM, including $124million spent
by the U.S. Government in 2014,4<5% of therapies were tested
in children. Only few have shown effectiveness, leading phys-
icians to question their efficacy.
Otitis media (OM) includes a spectrum of diseases, which
range from middle ear fluid collection (OM with effusion,
OME), to purulent fluid behind the tympanic membrane (acute
otitis media, AOM) and recurrent AOM (RAOM). Many
countries published different guidelines for OM treatment.
Currently, CAM therapies are either ignored or discouraged
those guidelines, even in countries where CAM is popular.5,6
Due to OM high prevalence, physicians may be asked their
opinion regarding CAM therapies for pediatric OM, but they may
often feel uncomfortable advisingparents due to lackof knowledge.
In order to fill the knowledge gap,we sought to reviewscientifically
the knowledge gained regarding CAM therapies for pediatric OM.
METHODS
We used the terms ‘‘complementary medicine’’ and/or
‘‘alternative medicine’’ in conjunction with ‘‘otitis media’’ and
‘‘children’’ in ourMEDLINE search (accessed via PubMed), andfrom January 1980 to September 2015.
trials (RCTs), prospective/retrospective
s in the English language reporting on any
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TABLE 1. Reported CAM Treatment Options for OM, According to OM Type
Treatment AOM RAOM OME Overall Efficacy
Acupuncture þ Effective with concomitant antibiotic therapy
Homeopathy þ þ þ Mild
Herbal medicine/phytotherapy þ Mild to moderate
Osteopathy þ þ þ Very few benefits
Chiropractic medicine þ Very few benefits
Xylitol þ þ Conflicting results. Problematic daily dosing
Ear candling þ Potentially hazardous
Vitamin D þ Questionable. Mainly for prevention
Probiotics (systemic/intranasal) þ þ þ Encouraging results
ve
Marom et al Medicine  Volume 95, Number 6, February 2016CAM treatment in the context of pediatric OM were included. If
the article was not published in English, we relied on the abstract
as it appeared in the search engine.Noauthors declared conflict of
interest. Ethics committee approval was not requested because it
is not needed for systematic reviews of the literature according to
the Israeli and Italian laws.
RESULTS
Table 1 summarizes the evidence gathered regarding the
efficacy of different CAM treatment options for OM in children.
ACUPUNCTURE
Acupuncture (needle puncturing) derives from traditional
Chinese medicine and involves inserting thin needles into the
body at specific points.2 According to acupuncture, the body’s
energy force, chi (qi), differentiates a corpse from a live human
being. Acupuncture balances and enhances chi to bring the body
into a healthy state. The auricle harbors numerous locations
which are punctured for the treatment of many diseases. Yet, 4
specific locations around the external canal are believed to be
the primary gatekeepers of the ear’s energy, and they are
punctured in OM cases (Figure 1). There is little understanding
AOM¼ acute otitis media, CAM¼ complementary and alternati
RAOM¼ recurrent otitis media.why acupuncture may be beneficial, but it is suggested that it
has immunomodulatory properties that may play a role in
clearance of middle ear fluid.7
FIGURE 1. Key locations for relieving ear pain in otitis media (OM)
in an earmodel: (1) tragus, (2) base of the triangular fossa, (3)mid-
helix, and (4) antitragus.
2 | www.md-journal.comFew studies concerning acupuncture for the treatment of
OM in humans have only been published, but not in English.8–10
In 2 studies in canines, acupuncture was evaluated for the
treatment of recurrent otitis episodes. At first, animals with
otitis were randomized to receive conventional therapy, and
either sham acupuncture or ‘‘directed’’ acupuncture. Over the
subsequent year, majority of the dogs in the acupuncture group
were otitis-free.11 The same authors reported that acupuncture
may enhance the effect of antibiotic treatment for otitis in
dogs.12 However, since the reported type of otitis is unclear,
and given that otitis externa usually affects canines, these
conclusions may not be attributable to humans.
HOMEOPATHY
Homeopathy is based on the ‘‘like cures like’’ (similia
similibus curentur) doctrine: a substance that causes the symp-
toms of a disease in healthy people would cure similar symp-
toms in sick people.1 Homeopaths generally prescribe remedies
that have a ‘‘symptom picture,’’ which they consider most
closely equates to the constellation of the patient’s symptoms.
Most remedies combine an extract of a natural substance,
combined with a synthetic compound, which enhances the
therapeutic effect. A list of homeopathic remedies for OM
treatment is shown in Table 2.
Research into the effects of homeopathic treatment for OM
is scant, and its quality is limited. The first prospective cohort
study comparing the use of homeopathy for RAOM with
conventional treatment was reported in 1997: 71% children
from the homeopathic group had fewer OM episodes, whereas
57% of the conventional group received treatment for OM.13
The unequal numbers between the homeopathic (103) and
conventional group,14 and the absence of randomization con-
siderably weakened the study’s validity. Two subsequent RCTs
also showed promising results. The 1st compared homeopathic
and placebo for AOM in 75 children from Seattle who presented
with otalgia and tympanic membrane bulging of 36 hours
duration. A significant decrease in symptoms at 24 and 64 hours
after treatment were observed in the homeopathy group, and
there were fewer treatment failures in this group after 5 days, 2
weeks, and 6 weeks, but they were not statistically significant.15
In another study from Jaipur, India, 81 young children with
AOM were randomly assigned to conventional (antipyretics,
analgesics) and homeopathy treatment groups. Nearly all chil-
medicine, OM¼ otitis media, OME¼ otitis media with effusion,dren in the conventional group eventually required antibiotics,
compared to none in the homeopathy group. The number of
children experiencing ‘‘cure’’ suggested that early homeopathic
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 2. Common Homeopathic Remedies for Otitis Media
Agent Common Indications Figure
Belladonna 1. Earache beginning suddenly with intense pain, with few prior symptoms of URTI (eg,
watery rhinorrhea)
2. Signs of uncomplicated AOM: bright red outer ear, ear canal, or eardrum without pus
formation, sudden high fever
3. Ear pain extending down into the neck, or accompanied with sore throat
Ferrum phosphate 1. Early stages of earaches before pus has formed; symptoms similar to Belladonna, but
not as sudden or severe
2. Alternatively, if Belladonna did not improve symptoms
Fe3(PO4)2
Hepar sulfate 1. Sharp, severe otalgia
2. Earache with by thick rhinorrhea or otorrhea
3. Irritability
4. Chilliness and aversion to the cold or uncovering; desire for warmth
5. Earache worse in cold or open air or from cold applications better from warmth; worse
at night
Pulsatilla 1. Mild disposition; craves affection and physical contact
2. Purulent rhinorrhea/otorrhea
3. Ear pain worse at night, even in a warm room
4. Worse in general from warmth, wants fresh air
5. Little or no thirst
Chamomilla 1. Extreme irritability
2. Severe ear pain
3. Symptoms are worse when stooping or bending over and improved by warmth or being
wrapped in warm covers
4. Watery rhinorrhea
Soluble mercurius 1. Apply when otorrhea is present
2. Earache worse from warmth and worse at night
3. Profuse, bad-smelling perspiration, head sweats
4. Increased salivation, puffiness of the tongue
Silica 1. Later stages of an earache: physical weakness and tiredness, chilliness, desire for warm
covering
2. Pain behind the ear in the region of the mastoid
3. Sweating about the head or on the hands or feet
Colloidal silver 1. Mild-moderate cases of OM
2. Submicroscopic particles of mineral silver in colloidal silver adhere to the cell walls of
harmful microorganisms, inhibiting enzyme production and, in effect, smothering
them
3. If the silver particles are small enough, they can even adhere to the DNA of viruses,
and disrupt their ability to replicate
AOM¼ acute otitis media, OM¼ otitis media, URTI¼ upper respiratory tract infection.
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treatment could have advantages beyond a ‘‘watch and wait’’
policy.16 The results of these trials are promising.
In an RCTwhich compared homeopathic and conventional
treatment in 33 children diagnosed with OME, 75% in the
homeopathic group had a normal tympanogram after 12months,
compared to 31% in the conventional group. A higher pro-
portion of children receiving homeopathic treatment had a
hearing loss <20 dB at follow-up, though the difference was
not statistically significant. In another prospective observational
study of 230 children receiving homeopathic treatment for
AOM, pain control was achieved in 40% of patients after
6 hours, and in further 33% of patients after 12 hours.17 The rate
of AOM resolution in the homeopathic group was 2.4 times
faster, without complications.
According to homeopathy, there is an ‘‘effectiveness gap’’
in the conventional approach for OM. Thus, it is argued that
homeopathy should be integrated into the treatment strategy for
OM.18 Nevertheless, other authors who published in esteemed
journals considered homeopathy to be no more effective than
placebo, and essentially dismissed the need for further RCTs.19,20
Herbal Medicine/Phytotherapy
Herbal medicine and homeopathy are interchangeable
practiced together and sometimes confused. Herbal medicine
is the use of plants for medicinal purposes.1 Herbal products are
generally considered as safe, though efficacy is unclear and side
effects may vary.
Phytotherapy is the study of the use of extracts of natural
origin as medicines or health-promoting agents. Although
standard pharmacology isolates an active compound from a
given plant, phytotherapy aims to preserve the complexity of
substances from a given plant. Phytotherapy avoids mixing
plant ingredients with synthetic substances.
Phytotherapy has been reported to be effective in the
management of ear pain in OM. Otic solutions, such as Otikon
(Healthy-On, Israel), which contains extracts of garlic bulb,
mullein flower, calendula flower and St. John’s wort herb in
olive oil, or Mullein Garlic (Equinox Botanicals, Rutland, OH,
USA), which contains extract of mullein flowers, garlic, yar-
row, calendula flowers, and vitamin E, were shown to be as
effective as oral amoxicillin and topical anesthetics due to their
presumed antimicrobial, antiinflammatory, immunostimulating
effects, and good penetration through the tympanic mem-
Marom et albrane.21,22 Yet, phytotherapy has been heavily criticized by
others, since the alleged antiinflammatory properties could not
be tested or confirmed in vitro.23,24
FIGURE 2. Common chiropractic maneuvers for otitis media (OM).
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Osteopathy is a noninvasive manual medicine that focuses
on total body health by treating and strengthening the muscu-
loskeletal framework.1 Its aim is to positively affect the body’s
nervous, circulatory, and lymphatic systems, leading to ‘‘’bal-
ance’’ and providing overall good health and well-being.
Osteopathic manipulative treatments (OMTs) are
occasionally used for acute and recurrent cases of OM. The
2 most common OMTs for OM include: ‘‘Galbreath’’ maneu-
ver, a movement of the mandible aimed to indirectly generate a
pumping action on the Eustachian tube (ET);25 and ‘‘Muncie’’
and ‘‘modified Muncie’’ techniques, the placement of a fin-
gertip on the Rosenmuller’s fossa to open the ET.26
In the largest study so far, combinations of OMTs with
antibiotics decreased the frequency of AOM episodes and the
insertion of tympanostomy tubes in otitis-prone children, when
compared to antibiotics without OMTs.27 Children who
received weekly treatments had fewer episodes of AOM
(P¼ 0.04), and fewer required tympanostomy tubes
(P¼ 0.03). Yet, there were no differences in the overall anti-
biotic use, tympanometry measurements, behavioral
parameters, and hearing results between both groups. When
considering the large drop-out rate (25%), these conclusions
are questionable. Other studies have shown that OMTs admi-
nistered adjunctively with standard care for children with AOM
resulted in faster resolution of middle ear effusion following
AOM, there are no serious adverse effects, and that OMTs may
change the progression of recurrent OM cases.14,28–30 The
methodology of these studies is lacking; the study groups were
small with high drop-out rates and lacked a control group.
Chiropratic
Chiropractic focuses on the diagnosis and treatment of
mechanical disorders of the musculoskeletal system, especially
the spine. Chiropractic medicine believes that disorders of the
musculoskeletal system affect the general health, via the ner-
vous system.2 The main techniques involve manipulations of
the spine, joints, and soft tissues.
It is hypothesized that spinal manipulation therapy (SMT)
mediates changes in the sympathetic and parasympathetic
neural activity via the biomechanical changes produced in
the spine during treatment. Another hypothesis suggests that
cervical SMT reduces tension within hypertonic muscles,
increasing both lymphatic drainage and ET opening.31 Chir-
Medicine  Volume 95, Number 6, February 2016opractic is thought to prevent recurrent infections by correcting
‘‘misalignments,’’ and allowing fluid drainage from the middle
ear (illustrating maneuvers are shown in Figure 2).
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Protective Characteristics of Xylitol
1. Inhibition of Streptococcus pneumoniae growth11
2. Inhibition of the attachment of S. pneumoniae and Haemophilus influenzae to nasopharyngeal cells11
3. Decreases the salt concentration of human airway surface that contains antimicrobial substances, including lysozyme, lactoferrin, human
b-defensins, and cathelicidin12
4. Increases the efficacy of the innate immune system13
Exposure to xylitol lowered cpsB (pneumococcal capsular locus) gene. expression, which changes the ultrastructure of the pneumococcal
14
Medicine  Volume 95, Number 6, February 2016 Complementary and Alternative Therapies for Otitis MediaA systematic report found only a limited quality of evi-
dence for SMT use in children with OM.31 Although there were
no serious adverse effects of SMT, there was no clear evidence
to support using SMT.
Xylitol
Xylitol is a 5-carbon sugar alcohol, which is naturally
found in low concentrations in the fibers of fruits and veg-
etables. Fair evidence found that xylitol reduced the incidence
of AOM episodes in healthy children.1 The alleged properties of
xylitol to prevent OM are summarized in Table 3.
In 1996, Uhari first published an RCT, in which xylitol
reduced AOM occurrence by 41%, and fewer children receiving
xylitol required antibiotics.34 Later, the same group showed that
xylitol was effective in AOM prevention among daycare tod-
dlers.35 Although 1 AOM episode(s) was observed in 41% of
the children who received control syrup, only 29% of the
children who received xylitol had AOM episode(s) (30%
decrease, 95% confidence interval [CI] 4.6–55.4). AOM inci-
dence decreased by 40% compared with control subjects in the
children who received xylitol chewing gum, and by 20% in the
lozenges group.
These encouraging results initiated additional studies. In
RCTs in which different xylitol remedies were used yielded less
convincing results. Xylitol was shown to be ineffective in chil-
drenwith indwelling tympanostomy tubes.When xylitolmixture,
capsule
6. Decrease biofilm production by S. pneumoniae32,33control mixture, control chewing gum, xylitol chewing gum, and
xylitol lozenges were given during an active upper respiratory
tract infection (URTI), there was no preventive effect for any o
FIGURE 3. Ear candling.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.fthe xylitol mixtures.36 Recent Cochrane review examined the
evidence gathered for the use of xylitol in preventing recurrent
OM, and found 4 RCT studies that met the criteria for analysis.37
Overall, it demonstrated a statistically significant reduction
(25%) in the risk of occurrence of OM among healthy children
in the xylitol group, compared with the control placebo group
(relative risk [RR] 0.75; 95% CI: 0.65–0.88; 95% CI: 0.12 to
0.03). Chewing gum and lozenges containing xylitol appeared
to be more effective than syrup; however, it emphasized that
children<2 years who are at the greatest risk of developing OM
cannot safely use lozenges or chewing gum.Most studies report a
5 times-per-day dosing schedule, which lowers the compliance in
most children. Concomitant increase of quantity in each dose
reduced the number of xylitol doses to 3-times-per-day, but
resulted in various side effects.
A recent National Institute of Health-funded study
examined if viscous xylitol solution at a dose of 5 g 3-times-
per-day could reduce the occurrence of clinically diagnosed
AOM among otitis-prone children 6 months through 5 years.32
Unfortunately, the results were discouraging, as there were no
significant differences in the occurrence of AOM and total
antibiotic use between the xylitol group versus the placebo
group. Therefore, the use of xylitol was not opted by many
national guidelines as a means to prevent OM.
Ear Candling
Ear candling, also known as ear coning or thermal-auri-
cular therapy, consists of placing a hollow candle in the ear
canal and lighting the other end33 (Figure 3). Ear coning has its
roots in the traditional healing practices of China, Greece,
Egypt, Tibet, and North America.
Ear candling claims to ‘‘purify the blood’’ and heal
children with OM through ‘‘’cleaning’’ of the middle ear cleft
by creating a ‘‘negative pressure.’’ Little research has been
performed on ear candling. Seely reported that ear candling is
implausible and demonstrably wrong, leading to deposit of
candle residue in the ear canal with no therapeutic effect on
extraction of cerumen or the middle ear.33 Furthermore, the
authors stated that this therapy may be harmful, causing ear
injuries (burns, occlusions of the ear canal, and tympanic
membrane perforation), as well as otitis externa.
Vitamin D Supplement
In addition to its role in bone metabolism and calcium
homeostasis, vitamin D plays a role in immunity and infec-
tion.38–43 In particular, it has been postulated that 25-hydro-
xyvitamin D [25(OH)D], the isoform that reflects the
individual’s vitamin D status, acts as an immunomodulator
of both innate and adaptive immune systems, by shifting the
T-helper cell pool toward Th2 status, inducing antimicrobial
www.md-journal.com | 5
peptide synthesis, that is, cathelicidin and b-defensins, and
inhibiting the production of pro-inflammatory cyto-
kines.38,40–43 Moreover, vitamin D is involved in the modu-
lation of macrophages and dendritic cells activities, and in
regulation of toll-like receptor mediated events in neutrophils.
Therefore, vitamin D status may influence the incidence and
severity of some bacterial and viral infections, as indicated by
previous clinical studies performed in patients with tuberculo-
sis, respiratory tract infections, and AOM.39,44,45
Cayir et al46 published a longitudinal cross-sectional study
conducted in 84 children aged 1 to 5 years with RAOM and in
108 comparable healthy controls. He found significantly
reduced mean serum 25(OH)D levels in children with RAOM
compared to controls (11.4 9.8 vs 29.2 13.9 ng/mL;
P< 0.05), and an increased percentage of children with serum
25(OH)D levels <20 ng/mL in the study group compared to
controls (69% vs 30%; P< 0.05). When vitamin D was given to
children with RAOM who also had vitamin D deficiency, the
occurrence of AOM and RAOM significantly dropped during
the 1-year follow-up period. In the authors’ opinion, vitamin D
quantities may play a role in the susceptibility to OM. These
data were confirmed by the same group,47 which has recently
reported in a single-blind, case–control study significantly
reduced serum 25(OH)D levels in 88 children with AOM
compared to 81 healthy controls (20.6 10.2 vs
23.8 10.3 ng/mL; P< 0.05).
Marchisio et al45 evaluated the relationship between
decreased vitamin D levels and the increased risk of RAOM.
They studied the possible effect of vitamin D supplementation
in reducing the number of AOM episodes in 116 otitis-prone
children (58 receiving vitamin D supplementation and 58
receiving placebo). They found that the number of children
experiencing at least 1 AOM episode was significantly lower in
the treatment group, when compared with the placebo group
(26/58 vs 38/58; P¼ 0.03), and that the mean number of global
AOM episodes (P¼ 0.03) and uncomplicated AOM episodes
(P< 0.001) occurring in the vitamin D group was significantly
lower, when compared to the control group. The likelihood of
AOM occurrence was significantly reduced in patients with
serum 25(OH) D levels 30 ng/mL. This study concluded that
vitamin D deficiency is frequent in otitis-prone children, and
that blood 25(OH)D concentrations 30 ng/mL are protective.
Despite these data, there is not enough evidence to support
a causative effect of vitamin D deficiency on the etiology and
pathogenesis of AOM, and to suggest a protective effect of
vitamin D supplementation in children with RAOM; further
controlled clinical trials are needed to solve these questions.
PROBIOTICS
Oral Probiotics
Probiotics are live microorganisms that offer health
benefits by modulating the microbial community and enhancing
host immunity.2 These effects can be obtained through inhi-
bition of pathogen colonization, production of bacteriocins, and
enhancement of both mucosal and systemic immunity.48
Commercial probiotics preparations are based on single or
multiple bacteria. Most of the data regarding preventive effi-
cacy of probiotics against infections have been obtained in
patients with gastrointestinal diseases, in whom it was demon-
strated that administration of probiotics can significantly reduce
Marom et althe risk of development of antibiotic-associated diarrhea.49
Data regarding the use of probiotics on OM have gathered
in the last few years, showing variable efficacy.50–52 In general,
6 | www.md-journal.comthe reduction in OM incidence in treated children was limited.
Hatakka et al53 evaluated the possibility that probiotics could
reduce the occurrence and duration of AOM episodes or the
nasopharyngeal carriage of otopathogens in otitis-prone chil-
dren. The study involved 309 children, aged 10 months to 6
years, who were randomised to consume for 24 weeks a
probiotic daily or a placebo capsule. The probiotic treatment
did not reduce the occurrence (probiotic vs placebo 72% vs
65%) or the recurrence (3 episodes) of AOM (probiotic vs
placebo 18% vs 17%), while a reduction in the occurrence of
recurrent URTIs was noticed in the probiotic group (OR for 4
URTIs¼ 0.56, OR for6 URTIs¼ 0.59). The administration of
probiotics did not modify the nasopharyngeal carriage of
Streptococcus pneumoniae or Haemophilus influenzae, but
increased the carriage of Moraxella catarrhalis (OR¼ 1.79),
confirming from a microbiological point of view the basis for
the negative results in prevention of AOM. These data are in
agreement with the work of Tapiovaara et al,54 who demon-
strated that LactobacillusGG is able to penetrate the middle ear,
but that its presence is not associated with a reduction in the
presence of pathogenic bacteria or viruses.
Rautava et al55 enrolled 81 infants requiring formula
feeding, who were randomized to receive either infant formula
supplementedwith the probioticsLactobacillus rhamnosusGG
and Bifidobacterium lactisBb-12 or placebo until the age of 12
months. During the first 7 months of life, the proportion of
AOM episodes was significantly lower (treated: 22% vs
placebo: 50%, P¼ 0.01), and antibiotics were significantly
less prescribed (treated: 31% vs placebo: 60%, P¼ 0.01).
However, when considering the whole 1st year of life, the
prevalence of AOM was not statistically different (treated:
13% vs 25%).
In a double-blind, placebo-controlled trial, Cohen et al56
assessed whether follow-up formula supplemented with pro-
biotics and prebiotics could reduce the risk of AOM. A total of
224 healthy infants aged 7 to 13 months were randomly
assigned to follow-up formula supplemented with probiotics
and prebiotics (Raftilose/Raftiline), or follow-up formula
alone. During the 12 months study period, the treatment and
the control groups did not differ in the incidence of AOM
(incidence rate ratio, 1.0, 95% CI: 0.8–1.2), lower URIs
incidence (IRR 0.9, 95% CI: 0.7–1.2), or number of antibiotic
treatment courses (RR 1.0, 95% CI: 0.8–1.2), which were
mainly prescribed for AOM (82%). The nasopharyngeal flora
composition did not differ in the 2 groups at any time during the
follow-up.
Topical Probiotics
Topical administration of probiotics has been considered
as a method to reduce the risk of recurrent AOM in children
when administered by nasal spray. The most largely studied
microorganism has been a-hemolytic Streptococcus (AHS),
taking into account that the presence in the nasopharynx could
interfere with survival and multiplication of pathogens more
frequently associated with AOM development.57
Roos et al58 enrolled 108 otitis-prone children and, after a
10-day antibiotic course, randomized them to receive a nasal
spray containing 5 AHS strains (selected among those coloniz-
ing the ETs opening, because of their superior inhibitory
activities against otopathogens) or a placebo solution. Both
Medicine  Volume 95, Number 6, February 2016streptococcal and placebo solutions were sprayed for a first 10-
day period and then resumed for 10 days starting from day 60 of
the study. During the 3-months follow-up, children who were
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
given AHS-supplemented spray experienced significantly more
cure from AOM (42% vs 22%, P¼ 0.02) and less recurrences
(40% vs 51%, P¼ 0.04). The author’s conclusions favored the
use of AHS to protect against RAOM.
Subsequently, Tano59 randomized 43 children to receive
with a nasal spray daily for 4 months a suspension of 10% skim
milk and 0.9% NaCl containing 5 selected AHS strains with
very good in vitro inhibitory activity on otopathogens, or skim
milk with 0.9% NaCl. The proportion of children with recur-
rences was similar in the 2 groups (treatment group: 44%;
placebo group: 40%) and no significant changes in the naso-
pharyngeal colonization of otopathogens was detected.
Skovbjerg et al60 studied the topical use of a nasal spray
containing S. sanguinis, L. rhamnosus, or placebo in children
with long-lasting OME before the insertion of tympanostomy
tubes. Complete or significant clinical recovery occurred in 7/
19 patients treated with S. sanguinis compared to 1/17 patients
in the placebo group (P¼ 0.05). In the L. rhamnosus treatment
group, no significant difference in cure rates was detected. It
should be taken into consideration that the study population
was small.
The negative results, in association with the potential risk
of infections directly due to the bacteria used for topical
treatment, have led to halting of research with these strains.
More recently, Streptococcus salivarius, an AHS isolated from
the pharynx of healthy subjects, has received attention. It is a
potential nasopharyngeal probiotic, thanks to its immunomo-
dulatory and antiinflammatory skills, its production of plasmin-
encoded bacteriocins and its good safety profile.57,61,62 Di
Pierro et al63 evaluated the role of S. salivarius K12 in pre-
venting recurrent streptococcal pharyngitis and AOM in 82
children aged 3 to 12 years with a recent history of recurrent oral
streptococcal pathology, who were randomized to be adminis-
tered an oral slow-release tablet containing 5 billion colony-
forming units of S. salivarius K12 (Bactoblis) and to a control
group. The 41 children who completed the 90-days treatment
had significantly fewer episodes of streptococcal pharyngeal
infections (92.2%) and/or of reported AOM (40%) during
the 90-day probiotic intake compared to the previous 12 months
(but the difference was not significant for AOM if adjusted for
the time period). A reduction in the reported incidence of
pharyngeal and middle ear infections by 65.9% was also
registered in the treatment group in the 6 months follow-up
after the treatment.
Marchisio et al64 recently reported the results of the 1st
study in which Streptococcus salivarius 24SMB, with signifi-
cant activity against AOM pathogens, was intranasally admi-
nistered in otitis-prone children. Children aged 1 to 5 years with
RAOM history were randomized 1:1 to receive an intranasal S.
salivarius 24SMB or placebo twice daily for 5 days each month
for 3 consecutive months and followed up for 6 months. The
number of children who did not experience any AOM was
higher among the children treated with the S. salivarius 24SMB
preparation than among those in the placebo group (30.0% vs
14.9%; P¼ 0.076) and among children colonized by S. salivar-
ius 24SMB after treatment compared to the noncolonized
(42.8% vs 13.6%; P¼ 0.03). Similar results were observed
when the children treated with antibiotics for AOM were
analyzed (67.8% vs 95.5%; P¼ 0.029).
Probiotics indeed seem a promising method in the pre-
Medicine  Volume 95, Number 6, February 2016vention of AOM and URI but, because of the contrasting results
of the available studies, further clinical evaluation is needed in
order to assess their true potential.
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.CONCLUSIONS
Despite the conservative therapeutic nature of CAM thera-
pies for OM, which do not include drugs or surgery, CAM is
currently not considered a treatment option for OM in the
medical community, due to the limited and confusing support-
ing scientific evidence. In our opinion, there may be some
benefits using homeopathy, phytotherapy, xylitol, vitamin D,
and probiotics for the prevention, and treatment of AOM. For
RAOM, we have noticed scant benefit for the use of probiotics
and vitamin D. For OME, a mild-moderate benefit was demon-
strated for the use of probiotics and xylitol. At this time, we
recommend that further studies should be conducted in order to
establish the additive value of the of CAM therapies for OM.
We propose RCTs in pediatric mild-moderate AOM cases, in
which antibiotics can be deferred or withheld, so the tested
CAM therapy will be evaluated versus placebo/no treatment.
We further suggest that trials should be conducted in which
infants fed with probiotic-enriched formulas will be evaluated
against others fed with standard formula, in terms of age of 1st
AOM episode and RAOM prevalence.
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